Association between Type 2 Diabetes Mellitus and Covid-19 Severity: A Literature Review
Asian Journal of Pharmaceutical and Clinical Research
; 16(5):13-18, 2023.
Artículo
en Inglés
| EMBASE | ID: covidwho-20236199
ABSTRACT
We conducted a review and evaluated the already documents reports for the relationship among diabetes and COVID-19. The review outcome shows that the COVID-19 severity seems to be greater among patients with diabetes as comorbidity. So, strict glycemic control is imperative in patients infected with COVID-19. Thus, world-wide diabetes burden and COVID-19 pandemic must be deliberated as diabetes increases the COVID-19 severity. Established on this, it is precise significant to follow specific treatment protocols and clinical management in COVID-19 patients affected with diabetes to prevent morbidity and mortality.Copyright © 2023 The Authors.
Coronavirus; covid-19; Diabetes; Infection; SARS-CoV-2; adult respiratory distress syndrome; cardiovascular disease; CD4+ T lymphocyte; computer assisted tomography; coronavirus disease 2019; deep vein thrombosis; disease association; disease severity; erythrocyte count; erythrocyte sedimentation rate; fasting blood glucose level; forced vital capacity; human; hyperglycemia; hypertension; hypoalbuminemia; in-hospital mortality; lactic acidosis; leukocyte count; lung embolism; M1 macrophage; meta analysis (topic); mortality rate; nausea; neutrophil count; non insulin dependent diabetes mellitus; prevalence; pyroptosis; review; risk factor; social distancing; upregulation; ventilator associated pneumonia; virus load; vomiting; 2 hydroxybutyrate dehydrogenase/ec [Endogenous Compound]; alanine aminotransferase/ec [Endogenous Compound]; angiotensin converting enzyme 2/ec [Endogenous Compound]; C reactive protein/ec [Endogenous Compound]; D dimer/ec [Endogenous Compound]; dapagliflozin; ferritin/ec [Endogenous Compound]; fibrinogen/ec [Endogenous Compound]; hemoglobin A1c/ec [Endogenous Compound]; hydroxymethylglutaryl coenzyme A reductase kinase kinase/ec [Endogenous Compound]; interleukin 1beta/ec [Endogenous Compound]; interleukin 6/ec [Endogenous Compound]; metformin; pioglitazone
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
EMBASE
Tipo de estudio:
Estudio experimental
/
Estudio pronóstico
/
Revisiones
Idioma:
Inglés
Revista:
Asian Journal of Pharmaceutical and Clinical Research
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS